Stoke Therapeutics (STU:0GT) Beginning Cash Position : €176.65 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Stoke Therapeutics Beginning Cash Position?

Stoke Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2024 was €176.65 Mil.

Stoke Therapeutics's quarterly Beginning Cash Position declined from Sep. 2023 (€180.49 Mil) to Dec. 2023 (€174.73 Mil) but then increased from Dec. 2023 (€174.73 Mil) to Mar. 2024 (€176.65 Mil).

Stoke Therapeutics's annual Beginning Cash Position declined from Dec. 2021 (€254.45 Mil) to Dec. 2022 (€137.32 Mil) and declined from Dec. 2022 (€137.32 Mil) to Dec. 2023 (€104.65 Mil).

Stoke Therapeutics Beginning Cash Position Historical Data

The historical data trend for Stoke Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stoke Therapeutics Beginning Cash Position Chart

Stoke Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

95.04

183.04

254.45

137.32

104.65

Stoke Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															106.59	176.21	180.49	174.73	176.65

Stoke Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Stoke Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Stoke Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Stoke Therapeutics (STU:0GT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stoke Therapeutics Inc (STU:0GT) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

STOK:USA

Address

45 Wiggins Avenue, Bedford, MA, USA, 01730

Website

https://www.stoketherapeutics.com

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. The company primarily operates in the U.S.

Stoke Therapeutics (STU:0GT) Headlines

No Headlines